 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, May 21, 2008, 28(21):5465-5472; doi:10.1523/JNEUROSCI.5336-07.2008
Previous Article | Next Article
Behavioral/Systems/Cognitive
Blockade of Endogenous Opioid Neurotransmission Enhances Acquisition of Conditioned Fear in Humans
Falk Eippert,1 Ulrike Bingel,2 Eszter Schoell,1 Juliana Yacubian,1 andChristian Büchel1 Departments of 1Systems Neuroscience and 2Neurology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
Correspondence should be addressed to Falk Eippert, Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. Email: f.eippert{at}uke.uni-hamburg.de
The endogenous opioid system is involved in fear learning in rodents, as opioid agonists attenuate and opioid antagonists facilitate the acquisition of conditioned fear. It has been suggested that an opioidergic signal, which is engaged through conditioning and acts inhibitory on unconditioned stimulus input, is the source of these effects. To clarify whether blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans, and to elucidate the neural underpinnings of such an effect, we used functional magnetic resonance imaging in combination with behavioral recordings and a double-blind pharmacological intervention. All subjects underwent the same classical fear-conditioning paradigm, but subjects in the experimental group received the opioid antagonist naloxone before and during the experiment, in contrast to subjects in the control group, who received saline. Blocking endogenous opioid neurotransmission with naloxone led to more sustained responses to the unconditioned stimulus across trials, evident in both behavioral and blood oxygen level-dependent responses in pain responsive cortical regions. This effect was likely caused by naloxone blocking conditioned responses in a pain-inhibitory circuit involving opioid-rich areas such as the rostral anterior cingulate cortex, amygdala, and periaqueductal gray. Most importantly, naloxone enhanced the acquisition of fear on the behavioral level and changed the activation profile of the amygdala: whereas the control group showed rapidly decaying conditioned responses across trials, the naloxone group showed sustained conditioned responses in the amygdala. Together, these results demonstrate that in humans the endogenous opioid system has an inhibitory role in the acquisition of fear.
Key words: fear conditioning; opioids; amygdala; human; functional magnetic resonance imaging; naloxone
Received Dec. 2, 2007; revised March 2, 2008; accepted April 4, 2008.
Correspondence should be addressed to Falk Eippert, Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. Email: f.eippert{at}uke.uni-hamburg.de
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2008 28: i.[Full Text]
This article has been cited by other articles:
A. von Leupoldt, T. Sommer, S. Kegat, F. Eippert, H. J. Baumann, H. Klose, B. Dahme, and C. Buchel
Down-Regulation of Insular Cortex Responses to Dyspnea and Pain in Asthma
Am. J. Respir. Crit. Care Med., August 1, 2009; 180(3): 232 - 238.
[Abstract] [Full Text] [PDF]
S. Cole and G. P. McNally
Complementary roles for amygdala and periaqueductal gray in temporal-difference fear learning
Learn. Mem., December 30, 2008; 16(1): 1 - 7.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|